Navigation Links
AIDS Action Observes HIV Vaccine Awareness Day: Reason to Hope
Date:5/18/2009

WASHINGTON, May 18 /PRNewswire-USNewswire/ -- Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone. There are over 1.1 million people living with the virus in the United States. It is a disease that impacts minority and poor communities disproportionately: African-Americans are seven times more likely to contract HIV, while the rate of infection among Hispanics is three times that of whites. Amidst this tragic reality, the ongoing search for an HIV vaccine gives us reason to hope. The HIV vaccine research field continues to advance, and 2009 marks a year of promise. Today, on May 18th, HIV Vaccine Awareness Day, AIDS Action urges everyone to help end the AIDS epidemic by supporting HIV vaccine research. We also thank the numerous volunteers, community educators, scientists and advocates for their efforts to support HIV vaccine research.

The best long term hope for controlling the AIDS epidemic here and abroad is the development of safe, effective and affordable HIV vaccines. Historically, vaccines have been the most powerful weapon against diseases like polio, measles and Hepatitis B. In fact, no major viral epidemic has been defeated without one. HIV vaccine research is part of a robust HIV prevention research agenda, and integral to a sustainable comprehensive response to the epidemic.

While researchers have not yet found a vaccine, there are reasons to be hopeful. Several large scale efficacy trials in humans have already been completed. While their results did not yield an effective vaccine, they prompted innovative researchers to focus on basic science, leading to greater insight into human immunology. Using the lessons of the past, scientists are currently designing better clinical trials. And, there are promising candidates in the HIV vaccine pipeline. Results in the largest vaccine trial of 16,000 study participants in Thailand are expected in late 2009. There are several other candidates in clinical trials, and a new trial in the United States will soon begin. In this past year alone, six novel approaches being tested in monkeys have shown unprecedentedly positive initial findings. AIDS Action believes the horizon is bright.

This HIV Vaccine Awareness Day, we must remind ourselves that a life-saving HIV vaccine is possible. To be sure, it will require our best scientific minds. It will also rely on commitment from our political leaders and global investment, as well as support from ordinary citizens. AIDS Action is committed to advocating for continued political commitment and optimizing the environment for HIV vaccine research through education and awareness building. Through its membership network of AIDS service organizations, health departments, health educators and community-based organizations across the country, AIDS Action is working to establish leadership and increase HIV vaccine awareness among key influencers and community and national leaders.

But we can't do it alone. We need your help. Stay informed. Learn about HIV vaccine research efforts, talk about HIV vaccine research with your family and friends, support a trial volunteer, contact your local trial site to become a volunteer or join a community advisory board. We encourage everyone to become involved in HIV Vaccine Awareness Day.

Learn more about events in your area, how you can help, and the facts about HIV vaccine research at http://www.bethegeneration.org/ and http://www.aidsaction.org/.

AIDS Action strives to end the HIV epidemic by advancing public policies that prevent new infections, provide care for people living with HIV and support the search for a cure. AIDS Action serves as the national voice for AIDS service organizations, health departments and a diverse network of community-based organizations across the country that provide services for people living with or affected by HIV infection.


'/>"/>
SOURCE AIDS Action
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mitchell and Jopari Say Green Transaction Initiatives Play Key Role in P&C and Group Health Industry Environmental Best Practices
2. OpenViBE: The first French software program enabling action through thought
3. Physician practice interactions with health plans cost $31 billion a year
4. Dr. Peter J. Capizzi of Stillwater Plastic Surgery Honored in Patient Satisfaction Survey
5. CriticalPoint(TM) Training Rated Excellent in Customer Satisfaction
6. Breast Cancer Action Sues to End Gene Patenting
7. Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
8. A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier
9. AIDS Action Welcomes Presidents Budget Increases Yet Expresses Distress With Failure to End Federal Ban on Syringe Exchange Funding
10. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
11. Polls Show Americans Concerned About Swine Flu, Taking Actions to Protect Themselves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh has posted a new publication this ... generation is a time like no other and society needs to understand the only way ... does not want to sound like an old bible beater because religion has a bad ...
(Date:1/20/2017)... ... ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality nutritional ... ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures its ... products to all clients at reasonable prices. At the ECRM trade show, it had ...
(Date:1/20/2017)... ... ... International Protein, a company based out of Australia that focuses on developing ... trade show in Hilton Head, SC. , International Protein was founded by Christine ... of products that would elevate her fitness regime. At this ECRM trade show, Envall ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well ... VW+ 002. The drinks have been produced in collaboration with Zlatan Ibrahimovic and ... your workout. , After a successful launch in Sweden last year, the next ...
(Date:1/20/2017)... ... ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went on to support ... author, Marlyn Ivey, born in Lynn Haven, Florida and at the age of 5, his ... of age, he joined the Navy and got married right out of boot camp. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... 2017  Abaxis, Inc. (NasdaqGS: ABAX ), ... and consumables for the medical and veterinary markets worldwide, ... results for the third quarter fiscal year 2017, ended ... p.m. ET on Thursday, January 26, 2017.  The Company ... year 2017 after the market closes on Thursday, January ...
Breaking Medicine Technology: